• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性腹膜后脂肪肉瘤的外科治疗

Surgical management of primary retroperitoneal liposarcomas.

作者信息

Karanikas I, Liakakos T, Koundourakis S, Papadopoulos A, Garsallah M, Dendrinos S

机构信息

2nd Surgical Department, General Hospital of Athens, Greece.

出版信息

Acta Chir Belg. 1993 Jul-Aug;93(4):177-80.

PMID:8237233
Abstract

During a 21-year period (1970-1991), 7 patients with primary retroperitoneal liposarcomas were treated surgically in our department. All the tumours were excised completely, and in 2 patients an additional nephrectomy was performed. Postoperatively 4 patients had adjuvant radiotherapy. Two other patients received adjuvant chemotherapy. Both of them had to be reoperated, because of a local recurrence 12 and 9 months after their first operation. There was one death on the first postoperative day, and 4 patients died 1 1/2-2 years after the initial operation. Two patients are still alive 34 and 22 months after their first operation with recurrent disease. Adjuvant therapy proved to be ineffective on the survival of our patients. The prognosis of retroperitoneal liposarcomas continues to be poor and the primary treatment has to be aggressive with complete resection of the tumor.

摘要

在1970年至1991年的21年期间,我科对7例原发性腹膜后脂肪肉瘤患者进行了手术治疗。所有肿瘤均被完整切除,2例患者还进行了肾切除术。术后4例患者接受了辅助放疗。另外2例患者接受了辅助化疗。他们两人均因首次手术后12个月和9个月出现局部复发而不得不再次手术。术后第一天有1例死亡,4例患者在初次手术后1.5至2年死亡。2例患者在首次手术后34个月和22个月仍存活,但有复发性疾病。辅助治疗对我们患者的生存无明显效果。腹膜后脂肪肉瘤的预后仍然很差,主要治疗方法必须积极,完整切除肿瘤。

相似文献

1
Surgical management of primary retroperitoneal liposarcomas.原发性腹膜后脂肪肉瘤的外科治疗
Acta Chir Belg. 1993 Jul-Aug;93(4):177-80.
2
[Recurrent retroperitoneal liposarcoma. Presentation of a case].[复发性腹膜后脂肪肉瘤。1例病例报告]
Arch Esp Urol. 1987 Sep;40(7):517-22.
3
Successful Re-resection for Locally Recurrent Retroperitoneal Liposarcoma at Four Years After Ex Vivo Tumor Resection and Autotransplantation of the Liver: A Case Report.体外肿瘤切除及肝脏自体移植术后四年局部复发性腹膜后脂肪肉瘤的成功再次切除:一例报告
Transplant Proc. 2016 May;48(4):1215-7. doi: 10.1016/j.transproceed.2016.01.026.
4
Giant retroperitoneal liposarcoma.巨大腹膜后脂肪肉瘤
World J Surg Oncol. 2008 Oct 31;6:115. doi: 10.1186/1477-7819-6-115.
5
[Giant retroperitoneal liposarcoma--case report].[巨大腹膜后脂肪肉瘤——病例报告]
Magy Seb. 2005 Jun;58(3):190-3.
6
Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.组织学亚型和手术切缘可预测腹膜后脂肪肉瘤的复发模式和生存率。
Ann Surg. 2003 Sep;238(3):358-70; discussion 370-1. doi: 10.1097/01.sla.0000086542.11899.38.
7
Giant dedifferentiated retroperitoneal liposarcoma.巨大去分化型腹膜后脂肪肉瘤
Int Surg. 2008 Jul-Aug;93(4):247-9.
8
[Liposarcoma of the retroperitoneal space].[腹膜后间隙脂肪肉瘤]
Vestn Khir Im I I Grek. 1987 May;138(5):43-6.
9
Long-term results of aggressive surgical treatment of primary and recurrent retroperitoneal liposarcomas.原发性和复发性腹膜后脂肪肉瘤积极手术治疗的长期结果
Chir Ital. 2001 Jan-Feb;53(2):149-57.
10
[Retroperitoneal liposarcoma. Two cases].[腹膜后脂肪肉瘤。两例]
Ann Urol (Paris). 1995;29(3):154-8.

引用本文的文献

1
Multidetector Computed Tomography Features in Differentiating Exophytic Renal Angiomyolipoma from Retroperitoneal Liposarcoma: A Strobe-Compliant Observational Study.多排螺旋计算机断层扫描在鉴别外生性肾血管平滑肌脂肪瘤与腹膜后脂肪肉瘤中的特征:一项符合STROBE标准的观察性研究。
Medicine (Baltimore). 2015 Sep;94(37):e1521. doi: 10.1097/MD.0000000000001521.
2
Computed tomographic distinction of perirenal liposarcoma from exophytic angiomyolipoma: a feature analysis study.计算机断层扫描鉴别肾周脂肪肉瘤与外生性血管平滑肌脂肪瘤:一项特征分析研究
J Comput Assist Tomogr. 2008 Jul-Aug;32(4):548-52. doi: 10.1097/RCT.0b013e3181507534.
3
Primary retroperitoneal liposarcoma: a case report and review of the literature.
Int Urol Nephrol. 1995;27(6):691-5. doi: 10.1007/BF02552133.